Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 15/05/2020
Investor Relations Contact 61 01/09/2018
Sales & Marketing - 01/05/2018
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/24 Option

Director

1,00,000 0.2570%
06/02/24 Option

Director

1,00,000 0.2570%
22/02/22 Sell

Chief Executive Officer

4,00,000 1.0717%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%-.--% - - 38
-0.30%-6.68%+27.12%+127.32% 1,20000Cr
+1.25%-5.35%+32.65%+78.98% 65TCr
+0.94%-2.99%+21.13%+106.30% 51TCr
-0.60%-1.95%+25.73%+67.00% 38TCr
+0.69%-9.50%+36.78%+30.83% 33TCr
+0.41%-4.70%+24.18%+50.18% 29TCr
+0.81%-4.08%-2.95%+31.59% 27TCr
-0.15%-6.45%+29.06%+65.76% 24TCr
-0.06%-0.98%+31.42%+122.83% 21TCr
Average -9.60%-4.76%+25.01%+75.64% 45TCr
Weighted average by Cap. +0.30%-5.19%+26.02%+87.88%
Logo Canntab Therapeutics Limited
Canntab Therapeutics Ltd is a Canada-based company. The Company provides solid oral dosage cannabis tablets to assist health and wellness journey.
Employees
-
  1. Stock Market
  2. Stocks
  3. CTABF Stock